IMC Chicago’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.19M Sell
136,500
-11,000
-7% -$733K ﹤0.01% 1599
2026
Q1
$9.26M Sell
147,500
-20,600
-12% -$1.43M ﹤0.01% 1335
2025
Q4
$11.2M Sell
168,100
-137,100
-45% -$8.86M ﹤0.01% 1146
2025
Q3
$20.5M Buy
305,200
+164,700
+117% +$13M 0.01% 784
2025
Q2
$12.3M Sell
140,500
-63,600
-31% -$4.99M 0.01% 935
2025
Q1
$13.9M Sell
204,100
-34,900
-15% -$2.85M 0.01% 733
2024
Q4
$18.6M Sell
239,000
-47,900
-17% -$3.55M 0.01% 635
2024
Q3
$19.2M Buy
286,900
+171,000
+148% +$14M 0.01% 564
2024
Q2
$13.1M Sell
115,900
-24,600
-18% -$3.11M 0.01% 678
2024
Q1
$19.5M Sell
140,500
-13,000
-8% -$1.63M 0.01% 463
2023
Q4
$19M Sell
153,500
-5,600
-4% -$572K 0.01% 466
2023
Q3
$14.8M Buy
159,100
+87,500
+122% +$9.86M 0.01% 445
2023
Q2
$9.2M Buy
71,600
+31,300
+78% +$3.79M 0.01% 530
2023
Q1
$4.68M Buy
40,300
+2,200
+6% +$246K 0.01% 658
2022
Q4
$4.31M Buy
+38,100
New +$4.18M 0.01% 644
2020
Q2
Sell
-51,600
Closed -$3.47M 910
2020
Q1
$3.47M Buy
+51,600
New +$3.21M 0.01% 390

Other funds holding DXCM

IMC Chicago's DXCM Position: Q2 2026 in Review

IMC Chicago sold out of DexCom (DXCM) in Q2 2026, closing a stake of 12,131 shares — an estimated $808K sold.

IMC Chicago first reported a position in DXCM in Q3 2023 and held it in 5 quarters. The position peaked at $3.68M in Q3 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • IMC Chicago reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 12,131 DexCom shares in Q2 2026, an estimated $808K.
  • IMC Chicago first reported a position in DexCom in Q3 2023 and held it in 5 quarters.
  • IMC Chicago's DexCom position peaked at $3.68M in Q3 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.